CapWealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

CapWealth Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-93	Closed	-$8K	–	296
2016 Q1	$8K	Buy	93 +87	+1,450%	+$7.78K	﹤0.01%	247
2015 Q4	$1K	Hold	6	–	–	﹤0.01%	262
2015 Q3	$1K	Hold	6	–	–	﹤0.01%	263
2015 Q2	$1K	Hold	6	–	–	﹤0.01%	277
2015 Q1	$1K	Buy	+6	New	+$662	﹤0.01%	295
2014 Q4	–	Sell	-6	Closed	-$1K	–	177
2014 Q3	$1K	Sell	6 -72	-92%	-$6.32K	﹤0.01%	349
2014 Q2	$7K	Hold	78	–	–	﹤0.01%	266
2014 Q1	$6K	Buy	+78	New	+$6.5K	﹤0.01%	290
2013 Q4	–	Sell	-60	Closed	-$4K	–	383
2013 Q3	$4K	Hold	60	–	–	﹤0.01%	379
2013 Q2	$3K	Buy	+60	New	+$3.47K	﹤0.01%	378

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Societe Generale $14.1B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

CapWealth Advisors's IBB Position: Q2 2016 in Review

CapWealth Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 93 shares — an estimated $8K sold.

CapWealth Advisors first reported a position in IBB in Q2 2013 and held it in 10 quarters. The position peaked at $8K in Q1 2016. 429 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

CapWealth Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
CapWealth Advisors sold 93 iShares Biotechnology ETF shares in Q2 2016, an estimated $8K.
CapWealth Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 10 quarters.
CapWealth Advisors's iShares Biotechnology ETF position peaked at $8K in Q1 2016.
429 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on CapWealth Advisors's 13F filing for Q2 2016, filed 3 Aug 2016.